Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.
Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Lilly Clinical Trial

12  Enrolling
22  Total Trials
Pinned
Conditions: Diabetic Peripheral Neuropathy
Drugs: LY3556050
Age
≥18 years
Phase
II
Conditions: Type 2 diabetes
Trial Name
ACHIEVE-2
Drugs: dapagliflozin, orforglipron
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes, Obesity
Drugs: Tirzepatide (LY3298176)
Age
18 - 75 years
Phase
II
Conditions: Type 2 diabetes
Trial Name
TRANSCEND-T2D-3
Drugs: retatrutide
Age
≥18 years
Phase
III
Conditions: Type 2 diabetes
Trial Name
TRANSCEND-T2D-2
Drugs: retatrutide, semaglutide
Age
≥18 years
Phase
III
Conditions: Obesity, Overweight, Type 2 Diabetes, Sleep Apnea
Trial Name
TRIUMPH-2
Drugs: Retatrutide
Age
≥18 years
Phase
III
Conditions: Obesity, Overweight, Chronic Kidney Disease with or without Type 2 Diabetes
Trial Name
TREASURE-CKD
Drugs: Tirzepatide
Age
≥18 years
Phase
II
Conditions: Type 2 Diabetes, Overweight at Increased Cardiovascular Risk
Trial Name
ACHIEVE-4
Drugs: Orforglipron (LY3502970), Insulin Glargine
Age
≥18 years
Phase
III
Conditions: Type 1 diabetes, Healthy volunteers
Drugs: LY3938577, insulin degludec, insulin lispro
Age
18 - 64 years
Phase
I
Conditions: Type 2 Diabetes
Trial Name
TRANSCEND-T2D-1
Drugs: retatrutide
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
ACHIEVE-5
Drugs: Orforglipron
Age
≥18 years
Phase
III
Conditions: Type 2 diabetes, Healthy volunteers
Drugs: LY3938577, insulin degludec
Age
18 - 70 years
Phase
I

Lilly Trial Alerts

Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.
1  Not Yet Enrolling
22  Total Trials
Conditions: Type 2 diabetes
Drugs: LY3209590
Age
10 - 17 years
Phase
I
9 
Completed Enrollment
22  Total Trials
Conditions: Type 2 Diabetes
Trial Name
ACHIEVE-3
Drugs: Orforglipron, Semaglutide
Age
≥18 years
Phase
III
Conditions: Obesity, Overweight, Type 2 Diabetes
Trial Name
ATTAIN-2
Drugs: Orforglipron
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
ACHIEVE-1
Drugs: Orforglipron
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
ACHIEVE-J
Drugs: Orforglipron
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
SURPASS-CVOT
Drugs: Tirzepatide, Dulaglutide
Age
≥40 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
SURPASS-EARLY
Drugs: Antihyperglycemic medication, Tirzepatide
Age
≥18 years
Phase
IV
Conditions: Type 2 Diabetes
Trial Name
QWINT-1
Drugs: LY3209590, Insulin Glargine, Insulin Efsitora Alfa
Age
≥18 years
Phase
III
Conditions: Type 2 Diabetes
Trial Name
SURPASS-SWITCH
Drugs: Dulaglutide, Tirzepatide
Age
≥18 years
Phase
IV
Conditions: Type 2 Diabetes
Trial Name
SURPASS-PEDS
Drugs: Tirzepatide
Age
10 - 18 years
Phase
III